Skip to main content
Equibles
VNDA logo

VNDA · Vanda Pharmaceuticals Inc.

Track VNDA — free

Use VNDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about VNDA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.22 +0.19 (+3.78%) At close · Aug 14
Market Cap
$315.62M
Shares
60.46M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
7,279,274 -1.9% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
75/100
Short interest 12.3% of shares — P93 Days to cover 9.0 — P87 Price vs VWAP -9.8% — P23 Short-volume trend +9.7% — P83 Short interest change +3.3% — P67 Worst FTD 0.10% of shares — P76

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 7,422,856 7,188,123 +234,733 9.00
    2026-07-15 7,188,123 7,342,818 -154,695 8.80
    2026-06-30 7,342,818 6,989,104 +353,714 7.87
    2026-06-15 6,989,104 6,811,524 +177,580 7.78
    2026-05-29 6,811,524 6,368,418 +443,106 6.80
    2026-05-15 6,368,418 6,196,446 +171,972 4.90
    2026-04-30 6,196,446 5,597,992 +598,454 5.76
    2026-04-15 5,597,992 5,310,265 +287,727 5.45
    2026-03-31 5,310,265 3,200,424 +2,109,841 2.39
    2026-03-13 3,200,424 4,346,005 -1,145,581 1.69
    2026-02-27 4,346,005 3,469,008 +876,997 1.00
    2026-02-13 3,469,008 3,224,168 +244,840 2.69
    2026-01-30 3,224,168 2,879,747 +344,421 4.07
    2026-01-15 2,879,747 2,335,804 +543,943 1.41
    2025-12-31 2,335,804 4,892,408 -2,556,604 1.00
    2025-12-15 4,892,408 4,642,254 +250,154 3.26
    2025-11-28 4,642,254 3,882,165 +760,089 3.60
    2025-11-14 3,882,165 3,983,691 -101,526 7.18
    2025-10-31 3,983,691 3,824,568 +159,123 5.34
    2025-10-15 3,824,568 3,665,733 +158,835 6.51
    2025-09-30 3,665,733 4,608,002 -942,269 7.57
    2025-09-15 4,608,002 4,654,733 -46,731 12.57
    2025-08-29 4,654,733 4,609,548 +45,185 11.25
    Showing 1–23 of 23 settlements
    Key facts CIK 1347178 CUSIP 921659108 13F (30d) 164 filings 160 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)